We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
SNOA

Price
2.41
Stock movement down
-0.47 (-16.32%)
Company name
Sonoma Pharmaceuticals Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Drug Manufacturers - Specialty & Generic
Markedsværdi
3.23M
Ent værdi
7.48M
Pris/omsætning
0.24
Pris/bog
0.60
Udbytte afkast
-
Udbyttevækst
-
Vekst år
-
FCF-udbetaling
-
Efterfølgende P/E
-
Fremtidig P/E
-
PEG
-
EPS-vekst
-47.04%
1 års afkast
-23.73%
3 års afkast
-66.41%
5 års afkast
-53.76%
10 års afkast
-43.48%
Senest opdateret: 2025-03-29

iO Charts is a Seeking Alpha partner

UDBYTTE

SNOA betaler ikke udbytte

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VÆRDIANSÆTTELSE

Værdiansættelsesforhold

Loading...
Værdiansættelsesforhold-data
Efterfølgende P/E-
Pris til OCF-
Pris til FCF-
Pris til EBITDA-
EV i forhold til EBITDA-

Værdiansættelse (salg/bogført værdi)

Loading...
Værdiansættelse (salg/bogført værdi)-data
Pris til omsætning0.24
Pris til egenkapital0.60
EV i forhold til salg0.55

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

ØKONOMI

Pr. aktie

Loading...
Data pr. aktie
Aktuelt antal aktier1.34M
EPS (TTM)-3.56
FCF pr. aktie (TTM)-1.49

Resultatopgørelse

Loading...
Resultatopgørelse-data
Omsætning (TTM)13.55M
Bruttofortjeneste (TTM)5.22M
Driftsindkomst (TTM)-4.28M
Nettoindkomst (TTM)-3.69M
EPS (TTM)-3.56
EPS (1 år frem)-

Marginer

Loading...
Marginer-data
Bruttomargin (TTM)38.52%
Driftsmargin (TTM)-31.56%
Fortjenstmargin (TTM)-27.21%

Balance

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Balancedata
Kontanter4.08M
Nettotilgodehavender3.16M
Omsætningsaktiver i alt12.22M
Goodwill0.00
Immaterielle aktiver0.00
Ejendomme, anlæg og udstyr417.00K
Sum aktiver13.69M
Kreditor770.00K
Kortfristet/nuværende langsigtet gæld244.00K
Summen af kortfristede forpligtelser3.31M
Sum gæld8.33M
Aktionærernes egenkapital5.35M
Materielle nettoaktiver0.00

Likviditet

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Kontantstrøm-data
Likviditet fra driften (TTM)-1.51M
Investeringsudgifter (TTM)35.00K
Fri pengestrøm (TTM)-1.54M
Udbetalt udbytte (TTM)0.00

Finansiel indkomst

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Data om finansiel indkomst
Egenkapitalafkast-68.87%
Afkast af aktiver-26.93%
Afkast af investeret kapital-66.41%
Kontant afkast af investeret kapital-27.84%

INFORMATION OM AKTIER

Aktiediagram

Loading...
Aktiekurs-data
Åbning2.82
Daglig høj2.87
Daglig lav2.28
Daglig volumen145K
Højeste gennem alle tider69300.00
1 års analytiker estimat19.50
Beta1.38
EPS (TTM)-3.56
Udbytte pr. aktie-
Ex-div dato-
Næste dato for resultatpræsentation-

Nedsidepotensial

Loading...
Nedsidepotensial-data
SNOAS&P500
Nuværende prisfald fra top notering-100.00%-9.34%
Højeste prisfald-100.00%-56.47%
Højeste efterår dato7 Mar 20259 Mar 2009
Gennemsnitlig fald fra toppen-90.58%-11.07%
Gennemsnitlig tid til nyt højdepunkt327 days12 days
Maks. tid til nyt højdepunkt4452 days1805 days

iO Charts is a Seeking Alpha partner

OPLYSNINGER OM VIRKSOMHEDEN
SNOA (Sonoma Pharmaceuticals Inc) company logo
Markedsværdi
3.23M
Markedsværdi kategori
Small-cap
Beskrivelse
Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye and nasal care, oral care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally. The company offers Lumacyn, a skin toner; Regenacyn, a prescription scar gel; Reliefacyn to alleviate red bumps, rashes, shallow skin fisures, sunburn, peeling, and eczema/atopic dermatitis; Gramaderm for the treatment of topical mild to moderate acne; Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription and over-the-counter product used to relieve skin irritations, lacerations, abrasions, and burns; Celacyn, a scar management gel; SebuDerm to manage and relieve the burning, itching, erythema, scaling, and pain associated with seborrhea and seborrheic dermatitis; and Pediacyn, an atopic dermatitis hydrogel. It also provides Microcyn, a HOCl-based topical line of products designed to stimulate expedited healing by targeting a range of pathogens; Ocucyn eyelid and eyelash cleanser; Ocudox for eye care; Sinudox for nasal irrigation; Microdacyn60 oral care solution to treat mouth and throat infections; and Podiacyn, a foot care product. In addition, the company offers MicrocynAH, an HOCl-based solution used to relieve common symptoms of hot spots, scratches, skin rashes post-surgical sites, and irritated animal skin; MicrocynVS, an animal care product; Nanocyn, a hospital-grade disinfectant; Acuicyn, an antimicrobial prescription solution for the treatment of blepharitis and the daily hygiene of eyelids and lashes; MucoClyns for use in emergencies and on mucous membranes, cuts, abrasions, burns, and body surfaces; and Endocyn root canal irrigation solutions. The company was formerly known as Oculus Innovative Sciences, Inc. and changed its name to Sonoma Pharmaceuticals, Inc. in December 2016. Sonoma Pharmaceuticals, Inc. was incorporated in 1999 and is based in Boulder, Colorado.
Personale
10
Investor relationer
-
SEC-indsendelser
Adm. direktør
Amy M. Trombly
Land
USA
By
Petaluma
Aktietype
Common stock
CCC-status
-
Utbyttefrekvens
-
ARRANGEMENTER OG PRÆSENTATIONER
ArrangementerPræsentationer
Loading...

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FORSTÅ FORRETNINGEN
Loading...